Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Neoplasms
×
Docetaxel
×
Clear all
Filters
3
NCT06989112
2026-03-12
DE-01
AstraZeneca
Phase 3
Recruiting
600 enrolled